House of Lords Business
Show full summary

Lord Hunt of Kings Heath to ask Her Majesty's Government what further proof of eligibility for treatment with liothyronine is required for those patients, in Clinical Commissioning Groups (CCG) who are members of the Pan Mersey Area Prescribing Committee, for whom an endocrinologist has confirmed levothyroxine treatment has not been suitable and has recommended they are prescribed liothyronine, and where the CCG is requiring an Individual Funding Request process be undergone before treatment can be permitted.  HL457

Question HL457: tabled on 28 October 2019 and due for answer by 11 November 2019

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Hunt of Kings Heath to ask Her Majesty's Government what further proof of eligibility for treatment with liothyronine is required for those patients, in Clinical Commissioning Groups (CCG) who are members of the Pan Mersey Area Prescribing Committee, for whom an endocrinologist has confirmed levothyroxine treatment has not been suitable and has recommended they are prescribed liothyronine, and where the CCG is requiring an Individual Funding Request process be undergone before treatment can be permitted.  HL457
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Hunt of Kings Heath
Labour
Life peer